Skip to content

Therapeutic effect of real-time TEAS on chemotherapy-induced nausea and vomiting

Therapeutic effect of real-time TEAS on chemotherapy-induced nausea and vomiting

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084368
Enrollment
Unknown
Registered
2024-05-15
Start date
2024-05-25
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chemotherapy-Induced Nausea and Vomiting

Interventions

Experimental group:After chemotherapy, the portable TEAS stimulator is worn for 5 days, and patients can decide whether to give the TEAS treatment at the Neiguan point on their own when nausea and vom

Sponsors

The Third Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Adult patients aged 20-60 years old, male and female, who meet the diagnostic criteria and are clearly diagnosed with malignant tumor stage I to III (without distant metastasis); (2) Karnofsky score>60 points (score below 60 points, many effective anti-tumor treatments cannot be achieved, therefore excluded); (3) Determine that chemotherapy will be performed and that the proposed chemotherapy plan includes drugs with moderate to high emetic effects, with or without the use of antiemetics in the treatment plan; (4) The expected survival time is 3 months or more; (5) Agree to participate in the study and be willing to provide written informed consent; (6) No other acupuncture treatment within 1 month.

Exclusion criteria

Exclusion criteria: (1) People with a history of central nervous system diseases, mental disorders, a history of psychiatric disorders, opioid addiction or dependence, extreme weakness, disability or immunodeficiency; (2) Patients with peripheral neuropathy such as peripheral neuropathy after chemotherapy that may cause TEAS to be unable to achieve effective treatment; (3)Those who are currently participating in or have participated in other clinical trials within the last 4 weeks; (4) Allergic constitution, systemic skin disease, bilateral "Neiguan" point skin incomplete can not be stimulated; (5)Failure to follow study instructions and cooperate with study procedures; (6)Concurrent radiotherapy or other anti-tumor therapy; (7)There are other health issues that may interfere with CINV symptoms, such as gastrointestinal disorders, migraines, and tinnitus

Design outcomes

Primary

MeasureTime frame
The number of chemotherapy-Induced nausea and vomiting;The degree of chemotherapy-Induced nausea and vomiting;

Secondary

MeasureTime frame
Life quality satisfaction;Mild depressive state;Mild anxiety state;

Countries

China

Contacts

Public ContactFang Junfan

The Third Affiliated Hospital of Zhejiang Chinese Medical University

fangjunfan0223@163.com+86 137 5432 8731

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026